Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Net Equity Issued and Repurchased (2021 - 2026)

Surrozen (SRZN) posted quarterly Net Equity Issued and Repurchased of $50.0 million for Q1 2026, down 34.54% year-over-year from $76.4 million in Q1 2025, and up 1328.16% quarter-over-quarter from $3.5 million in Q4 2025.

Analysis

Surrozen (SRZN) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Surrozen's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $50.0 million for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased fell 34.54% year-over-year to $50.0 million; the TTM figure through Mar 2026 stood at $48.3 million (down 47.73% YoY), while the FY2025 annual figure was $74.7 million, up 365.64% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $50.0 million, up from $3.5 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $76.4 million in Q1 2025, with the low at -$5.2 million in Q2 2025.
  • The 3-year median for Net Equity Issued and Repurchased is $9.8 million (2024), against an average of $23.5 million.
  • The sharpest annual moves came in 2025 and 2026: Net Equity Issued and Repurchased plunged 132.32% in 2025, then plunged 34.54% in 2026.
  • Surrozen's Net Equity Issued and Repurchased stood at -$1000.0 in 2024, then surged by 350200.0% to $3.5 million in 2025, then soared by 1328.16% to $50.0 million in 2026.
  • Business Quant data shows SRZN's Net Equity Issued and Repurchased at $50.0 million in Q1 2026, $3.5 million in Q4 2025, and -$5.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Surrozen 263.35 Mn 263.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 50.00 Mn
Dec 31, 2025 3.50 Mn
Jun 30, 2025 -5.19 Mn
Mar 31, 2025 76.39 Mn
Sep 30, 2024 -1,000.00
Jun 30, 2024 16.04 Mn
Dec 31, 2021 125,000.00